癌相关成纤维细胞
肿瘤微环境
细胞外基质
肿瘤进展
癌症研究
癌症
间质细胞
基质
癌细胞
成纤维细胞
生物
细胞
腺癌
免疫组织化学
病理
医学
细胞生物学
免疫学
细胞培养
肿瘤细胞
遗传学
作者
Jiayu Zhang,Shiqi Lu,Tong Lü,Donghui Han,Keying Zhang,Lunbiao Gan,Xinjie Wu,Yu Li,Xiaolong Zhao,Zhengxuan Li,Yajie Shen,Sijung Hu,Fa Yang,Weihong Wen,Weijun Qin
标识
DOI:10.3389/fphar.2023.1121586
摘要
Abstract Background Cancer-associated fibroblasts (CAFs) promote tumor progression through extracellular matrix (ECM) remodeling and extensive communication with other cell types in the tumor microenvironment. However, most CAF-targeting strategies have failed in clinical trials due to the heterogeneity of CAFs. Hence, we aimed to identify the tumor-promoting CAFs and determine their specific membrane molecules to ensure precise targeting. Methods We integrated multiple single-cell RNA sequencing (scRNA-seq) datasets across different tumors and adjacent normal tissues to identify the tumor-promoting CAF subtype. We tried to analyze the origin of these tumor-promoting CAFs, and we also performed a cell-type deconvolution analysis to examine the association between the tumor-promoting CAF subtype and prognosis in TCGA cancer cohorts. Results We found that COL11A1+ fibroblasts represent a novel CAF subtype that only exist in tumor tissues but not in normal tissues and named them cancer-specific fibroblasts (CSFs). By using pseudotime analysis, we revealed that these CSFs were transformed from normal fibroblasts. CSFs represent a more activated CAF subtype and may promote tumor progression by regulating ECM remodeling and inhibiting antitumor immune responses. We also identified that CSFs specifically express the surface molecules LRRC15, ITGA11, SPHK1 and FAP, which could distinguish CSFs from other fibroblasts. Conclusions We identified COL11A1+ fibroblasts as a novel subtype of CAFs that specifically exist in tumor tissues and named them CSFs. These CSFs specifically express LRRC15, ITGA11, SPHK1 and FAP, which could be used as therapeutic targets for cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI